
Avant Assessment
Streamlining a top language assessment platform
We helped Avant Assessment strengthen its language testing products from both the bottom up and the top down

BEFORE
Online language testing leader Avant had grown its platform offerings quickly, but not strategically
Its fragmented network of products had become hard to manage and clunky to use
Infrastructure inconsistencies and tech debt were blocking further expansion and evolution

AFTER
Consolidated eight non-standardized products into one cloud-based platform
Hosting costs cut by 75%
Modernized interface dramatically improved product adoption and engagement, spurring immense growth for its team, revenue, and customer base

Challenge
A new chapter in online language testing
Process
Bringing it all together


Solution
Breaking the sound barrier
Solution
Reassessing the user experience


Solution
Remodeled for modern users
Solution
Results you can see


Praise from our clients

David Bong
Avant Assessment, CEO

Kyle Ennis
Avant Assessment, VP Educational Products
Featured technologies

React
- Data visualization & charting
- Novel web-based voice recording feature
- Cypress end-to-end testing

Kotlin & Java
- Spring Boot framework
- Hibernate & Postgresql
- Extensive unit testing
- Robust Datadog (APM) intergrations
- QR code processing pipeline for handwritten work submissions

Amazon Web Services (AWS) Cloud Migration
- Migrated all services from data center to AWS
- Infrastructure-as-code via CloudFormation & Docker
- CI/CD & automated build
- Multiple environments with auto-scaling
- Audio format optimization pipeline via SQS

Compliance Support
- WCAG – Web Content Accessibility Guidelines
- GDPR
- FERPA

Extensive & Complex Technology Migration
- Merging of multi-year forked codebase
- Graceful merging of three deployments into one
- Planning allowed minimal downtime

up next
Securing user engagement and $26M+ in funding
We helped BlueNote Therapeutics implement a group connectivity feature to complete their cancer patient support app, unlocking series A funding and fast-tracking them for FDA approval